Can Methadone Cause Insomnia and Sleep Problems?

Methadone is strongly linked to insomnia and a range of other sleep disturbances. A systematic review and meta-analysis of 38 studies estimated that roughly three out of four people on methadone maintenance treatment qualify as poor sleepers, with future studies likely to find prevalence rates anywhere from half to over ninety percent of patients.¹ The sleep trouble is not just one thing, though. Methadone disrupts sleep at several levels simultaneously, from how long you stay asleep to how you breathe while sleeping, and the causes turn out to be a tangle of the drug itself, the conditions it treats, and the problems that often travel alongside opioid use disorder.

How Common Is the Problem

The numbers are strikingly high. That meta-analysis pooled data from studies using a well-known sleep questionnaire and found a weighted prevalence of about 75% for poor sleep quality among methadone-maintained patients.¹ The range across individual studies was wide, reflecting differences in patient populations, doses, and how long people had been on methadone. But even the low end of that range suggests that poor sleep is the norm, not the exception, in this group. Insomnia-level complaints, excessive daytime sleepiness, and nightmares all show up frequently in research on methadone patients.

To put the number in perspective, the general population typically shows poor sleep quality rates that are a fraction of this. The gap is large enough that sleep disruption qualifies as one of the most common side effects of long-term methadone treatment, even if it rarely gets as much attention as other concerns like constipation or hormonal changes.

What Methadone Does to Sleep Architecture

Sleep is not a single uniform state. It cycles through lighter and deeper stages, including slow-wave sleep (the deepest, most restorative phase) and REM sleep (when most vivid dreaming occurs). Methadone interferes with this structure in consistent ways. Compared to healthy controls, people on methadone have lower sleep efficiency, meaning they spend more of their time in bed actually awake. They get less slow-wave sleep, less REM sleep, and more of the lighter Stage 2 sleep that does not provide the same restorative benefits.² They also wake up more often during the night.³

The practical consequence is that even when someone on methadone sleeps for a reasonable number of hours, the sleep they get is shallower and more fragmented. They wake feeling unrested. Daytime sleepiness scores in methadone patients are consistently elevated compared to controls, and those scores track with the loss of deep sleep specifically.³ This helps explain why some patients report sleeping “enough” hours but still feeling exhausted.

The mechanism behind this likely involves opioid effects on brain regions that promote sleep. Opioids can inhibit sleep-promoting neurons in a part of the hypothalamus that acts as a switch between wakefulness and sleep.⁴ When those neurons are suppressed, the transition into deep sleep becomes harder to achieve and maintain.

Central Sleep Apnea and Breathing Problems at Night

One of the more serious and underrecognized ways methadone disrupts sleep is through its effect on breathing during sleep. About 30% of patients on stable methadone maintenance in one study had central sleep apnea above a clinically meaningful threshold, while none of the healthy controls did.⁵ Central sleep apnea is different from the more familiar obstructive type: rather than the airway physically collapsing, the brain temporarily stops sending the signal to breathe. The person pauses breathing, blood oxygen dips, and the brain jolts awake just enough to restart the process, fragmenting sleep without the person necessarily being aware of it.

Methadone blood concentration was the strongest predictor of central apnea severity in that study.⁵ Separate research confirmed this connection, finding that higher methadone blood levels correlated with greater breathing irregularity during sleep.⁶ Combining opioids with benzodiazepines appears to raise this risk further. A review of the evidence found credible support for a strong relationship between opioids and sleep-disordered breathing, with methadone specifically, high opioid dosing, and concurrent benzodiazepine use all flagged as risk factors.⁷

This means that someone on methadone who feels like they slept all night but wakes up exhausted could have undiagnosed central sleep apnea. The arousals are too brief to remember, but they chop sleep into fragments that prevent the brain from cycling through restorative stages. If you are on methadone and feel persistently unrested despite apparently adequate sleep time, a sleep study can pick up what questionnaires alone would miss.

Does the Dose Matter

You might expect that higher methadone doses would cause worse sleep, and some early studies found hints of that pattern. But the overall evidence is surprisingly mixed. A scoping review that looked across multiple studies found no consistent relationship between methadone dose and most self-reported sleep measures.⁸ One study found a correlation between dose and sleep quality scores that disappeared after accounting for chronic pain, benzodiazepine use, and psychiatric conditions. Another found links between doses above 100 milligrams and sleep quality in simple comparisons, but the association vanished in more rigorous analysis adjusting for other variables. A study of patients on high-dose methadone (above 150 milligrams) did find less deep sleep compared to a low-dose group, yet sleep continuity and overall sleep quality ratings did not differ.⁸

One area where dose does seem to matter more reliably is nightmares. A Chinese study of over 600 methadone patients found that doses above 70 milligrams were independently associated with frequent nightmares.⁸ And for breathing problems specifically, higher methadone blood concentrations correlate with worse central sleep apnea, as discussed above. So the dose-sleep relationship depends on which aspect of sleep you are measuring. Breathing disturbances track more closely with methadone levels; subjective insomnia symptoms seem more driven by the cluster of other problems that come along with opioid use disorder.

It Is Not Just the Methadone

One of the most important findings in this research is that methadone itself may not be the primary driver of insomnia for many patients. When researchers carefully separate out contributing factors, depression, anxiety, chronic pain, nicotine dependence, and benzodiazepine use consistently emerge as powerful independent predictors of poor sleep.⁹ In one study of methadone patients, those with chronic pain had lower sleep efficiency and more time spent awake compared to those without pain, and the difference in perceived sleep quality was driven by pain and benzodiazepine abuse rather than the methadone dose itself.¹⁰

Anxiety severity appears to operate on a gradient: as anxiety worsens from mild to severe, sleep quality deteriorates in step. The same holds for depression.¹⁰ Given that anxiety, depression, and chronic pain are extremely common in people with opioid use disorder, this creates a feedback loop: the conditions that led someone to methadone treatment also independently wreck their sleep, making it hard to tell where the drug’s effect ends and the comorbidities begin.

This has a practical implication. If you are on methadone and sleeping poorly, adjusting the methadone dose may not be the most productive lever to pull. Addressing untreated depression, managing chronic pain, cutting down on benzodiazepines, or treating anxiety might yield larger improvements in sleep than a dose change would.

Methadone Versus Buprenorphine for Sleep

People sometimes wonder whether switching from methadone to buprenorphine would help their sleep. The evidence here is fairly clear and probably disappointing: it probably would not. A study that compared sleep in patients on buprenorphine versus methadone using both objective lab measurements and questionnaires found no differences in sleep continuity or sleep architecture between the two groups.¹¹ Separate research looking at insomnia rates found they were similarly high in both buprenorphine-maintained and methadone-maintained patients, and neither group differed substantially in how opioid dose related to sleep complaints.¹²

What did differ between those groups was excessive daytime sleepiness, which was somewhat more common in methadone patients (about 23%) than buprenorphine patients (about 14%), though both were elevated compared to a reference group.¹² Interestingly, people with opioid use disorder who were not on any medication-assisted treatment actually had the worst sleep of all three groups, suggesting that treatment itself is not the main culprit. The sleep problems appear to be deeply embedded in opioid use disorder as a condition, not unique to one medication.

Sleep During Withdrawal and Tapering

If methadone maintenance treatment causes sleep trouble, you might think that tapering off would help. In the short term, at least, the opposite tends to happen. Insomnia is one of the hallmark symptoms of opioid withdrawal, and it can be severe. A study comparing different opiate withdrawal methods found that sleep was disturbed in both groups undergoing withdrawal, including the group being tapered off using methadone. The methadone-assisted group had somewhat less severe sleep disturbance than the alternative approach, but sleep difficulties were still present.¹³

This creates a frustrating bind: staying on methadone disrupts sleep, but coming off it can make sleep even worse for a period. Over the longer term, people who successfully taper and remain abstinent generally see sleep improve, but the withdrawal period is a known risk window for relapse, and severe insomnia during that window can make it harder to stay the course.

Restless Legs, Limb Movements, and Other Nighttime Disruptions

Beyond insomnia and apnea, methadone can be involved in sleep-related movement disorders. Opioids interact with the dopamine system, and disruptions to dopamine signaling are implicated in restless legs syndrome and periodic limb movement disorder during sleep.¹⁴ Paradoxically, at low doses methadone has actually been used to treat severe restless legs syndrome that did not respond to standard dopamine-based therapies: in one series, patients on low-dose methadone (averaging around 15 milligrams) reported at least a 75% reduction in restless legs symptoms.¹⁵

This duality underscores how complicated the relationship between opioids and sleep is. The same drug that can calm restless legs at one dose can contribute to sleep fragmentation, breathing disruption, and movement disorders through other pathways. What matters is the dose, the individual, and which sleep mechanisms are most affected in a given person.

The Role of Genetics

Not everyone on methadone sleeps equally poorly, and genetics appear to play a role in who is more vulnerable. Researchers have identified a specific combination of gene variants in the mu-opioid receptor gene (OPRM1) that was associated with better sleep quality among methadone-maintained patients. Patients carrying a particular diplotype had meaningfully lower sleep disturbance scores compared to those without it.¹⁶ This kind of finding is still early-stage and not ready for clinical use, but it fits with broader observations that individual variation in opioid receptor biology influences how much sleep disruption a given person experiences on the same medication.

What Helps

Given how common and multifaceted methadone-related sleep problems are, you would hope for a menu of proven treatments. The reality is more modest, but a few approaches have shown promise.

Cognitive behavioral therapy for insomnia, sometimes called CBT-I, is the best-supported non-drug approach. A randomized trial tested CBT-I specifically in methadone-maintained patients with insomnia and found it produced significantly greater improvements in sleep quality compared to a basic psychotherapy control, with benefits measurable at both five and eight weeks.¹⁷ CBT-I focuses on restructuring sleep-related habits and thought patterns rather than adding another medication, which makes it appealing for a population already managing multiple drugs.

On the medication side, results have been mixed. A pilot crossover trial found that mirtazapine improved total sleep time by an average of 23 minutes, shortened the time it took to fall asleep by 23 minutes, and modestly increased sleep efficiency.¹⁸ Mirtazapine has sedating properties and also treats depression, which makes it a reasonable option given how closely depression and sleep problems overlap in this population. By contrast, trazodone, a commonly prescribed sleep aid, failed to improve either subjective or objective sleep measures in a controlled trial of methadone-maintained patients.¹⁹ This is worth noting because trazodone is frequently prescribed for insomnia in general practice, and a prescriber unfamiliar with this research might reach for it as a default.

An herbal preparation from traditional Chinese medicine, Suan Zao Ren Tang, showed statistically significant improvements in both sleep quality scores and sleep efficiency in a four-week placebo-controlled trial, with only mild side effects reported.²⁰ This is a single trial, so the evidence is preliminary, but it adds one more option to a limited toolkit.

Sex Differences in Methadone-Related Sleep Problems

There is some evidence that men and women on methadone may experience different patterns of breathing disruption during sleep. Research has noted that women may experience more significant respiratory depression from opioids than men, a difference thought to relate to slower responses in peripheral chemoreceptor pathways that detect drops in blood oxygen.²¹ However, when researchers looked at insomnia and daytime sleepiness complaints, they did not find significant differences between men and women.¹² So the subjective experience of poor sleep may be similar across sexes, even if the underlying physiology of breathing disruption differs.

When Staying on Methadone Improves Things Over Time

The picture is not entirely bleak. There is evidence that for patients who remain stable on methadone and stay away from other substances, sleep and cognitive function can improve over the course of treatment. A study following patients over a year of methadone maintenance found that sleep quality scores and stress scores both improved significantly among those who did not abuse other substances during that year. Patients who continued using other drugs alongside methadone saw the opposite trend: their sleep and stress worsened.²² This reinforces the finding that much of the sleep trouble in this population comes from factors beyond methadone itself, including ongoing polysubstance use, untreated mental health conditions, and chronic pain.

It also means that patients in the early months of methadone treatment, when sleep tends to be at its worst, should not assume that their current sleep problems are permanent. Stabilization on methadone, combined with treatment of co-occurring conditions, can lead to meaningful improvement for many people.

Circadian Disruption

Beyond direct effects on sleep stages and breathing, there is growing interest in whether opioids, including methadone, disrupt the body’s circadian clock. Researchers have highlighted bidirectional relationships between opioid use and circadian rhythms, with opioids potentially interfering with the normal daily cycles of melatonin and stress hormones that help regulate the sleep-wake pattern. Many people entering methadone treatment have spent months or years with chaotic sleep schedules driven by cycles of intoxication and withdrawal, and the circadian system may take considerable time to reset even after methadone stabilizes their opioid levels. This is an area where the science is still being assembled, but it suggests that basic sleep hygiene measures like consistent wake times, light exposure in the morning, and avoiding screens before bed may matter even more for methadone patients than for other people struggling with insomnia, because their circadian systems may need more external anchoring to recover normal timing.

1
PubMed Central. Prevalence of sleep-related symptoms in patients receiving methadone maintenance treatment: a systematic review and meta-analysis
2
PubMed. Sleep-disordered breathing in stable methadone programme patients: a pilot study
3
Psychiatry Research. Nocturnal sleep architecture disturbances in early methadone treatment patients
4
American Journal of Respiratory and Critical Care Medicine. Opioid Use Disorder, Sleep Deficiency, and Ventilatory Control: Bidirectional Mechanisms and Therapeutic Targets
5
PubMed. Central sleep apnea in stable methadone maintenance treatment patients
6
PubMed Central. Respiratory Variability during Sleep in Methadone Maintenance Treatment Patients
7
Pain Medicine. Opioid Therapy and Sleep Disorders: Risks and Mitigation Strategies
8
PubMed Central. Associations Among Sleep, Pain, and Medications for Opioid Use Disorder: a Scoping Review
9
PubMed. Sleep disturbances among methadone maintained patients
10
PubMed Central. Quality of Sleep and Related Factors in Individuals Undergoing Methadone Maintenance Treatment
11
PubMed Central. Multimodal assessment of sleep in men and women during treatment for opioid use disorder
12
PubMed. Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment
13
PubMed. Insomnia among addicts during supervised withdrawal from opiates: a comparison of oral methadone and electrostimulation
14
PubMed Central. Parasomnias and sleep-related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects
15
PubMed. Methadone for refractory restless legs syndrome
16
PubMed Central. The AC/AG Diplotype for the 118A>G and IVS2 + 691G>C Polymorphisms of OPRM1 Gene is Associated with Sleep Quality Among Opioid-Dependent Patients on Methadone Maintenance Therapy
17
Iranian Journal of Medical Sciences. The Effect of Cognitive Behavior Therapy in Insomnia due to Methadone Maintenance Therapy: A Randomized Clinical Trial
18
PubMed Central. A pilot crossover trial of sleep medications for sleep-disturbed methadone maintenance patients
19
PubMed Central. Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial
20
PubMed Central. Clinical Efficacy of Traditional Chinese Medicine, Suan Zao Ren Tang, for Sleep Disturbance during Methadone Maintenance: A Randomized, Double-Blind, Placebo-Controlled Trial
21
PubMed Central. Obstructive Sleep Apnea is More Common than Central Sleep Apnea in Methadone Maintenance Patients with Subjective Sleep Complaints
22
PubMed Central. Improvement in Cognitive Performance after One Year of Methadone Maintenance Treatment